| |
IHS Global Insight Launches World Markets
Ophthalmology Service
How are pharmaceutical companies and regulatory bodies dealing
with increasing costs of—and market access barriers to—new
ophthalmology drugs?
What happens when new products change the competitive landscape?
What is in pipeline development that may alter the dynamics of the market?
IHS Global Insight's new World Markets Ophthalmology service is a comprehensive online tool designed to answer precisely these kinds of questions.
With coverage of over 500 drugs for over 9 disease areas, World Markets Ophthalmology allows you to:
- Understand how approvals and reimbursement were secured—or not secured—based on clinical endpoints, design, and results, as well as pricing
- Compare and break down the cost of drugs in each of the major disease areas
- Understand the key market access barriers to new ophthalmology drugs
- Find new licensing opportunities and key areas of research and development
- Assess the risk posed by drugs under development based on disease, drug class, and manufacturer
Complimentary downloads:
Macular Degeneration disease profile taken from the World Markets Ophthalmology Service
World Markets Ophthalmology brochure
Register for a free sample of our World Markets Ophthalmology Service today.
|
|
|
